Canature Health Technology Co., Ltd. (SHE:300272)
China flag China · Delayed Price · Currency is CNY
7.59
+0.01 (0.13%)
Feb 11, 2026, 3:04 PM CST

SHE:300272 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
1,7811,6791,6591,6451,4891,170
Other Revenue
9.169.1612.5115.6722.7111.02
1,7901,6891,6721,6611,5111,181
Revenue Growth (YoY)
6.29%1.00%0.67%9.87%27.97%12.22%
Cost of Revenue
1,1051,0411,0561,1121,010676.73
Gross Profit
685.36647.28615.87548.75501.96504.39
Selling, General & Admin
415.69413.52384.05346.17304.05327.11
Research & Development
69.0267.576563.9451.4932.63
Other Operating Expenses
4.395.585.839.043.26-7.04
Operating Expenses
489.25486.61457.05419.71361.57353.3
Operating Income
196.11160.67158.82129.04140.39151.09
Interest Expense
-35.16-34.48-28.44-16.85-16.28-15.05
Interest & Investment Income
24.2522.5514.875.5432.260.64
Currency Exchange Gain (Loss)
19.7519.759.5810.120.84-6.75
Other Non Operating Income (Expenses)
-11.71-5.22-4.41-9.23-5.48-12.25
EBT Excluding Unusual Items
193.24163.27150.41118.63151.72117.68
Impairment of Goodwill
----15.32-5.82-21.37
Gain (Loss) on Sale of Investments
-52.65-33.54.662.6-2.43-55.76
Gain (Loss) on Sale of Assets
-0.32-0.172.331.4-0.7-0
Asset Writedown
0.21----0.19-0.08
Legal Settlements
-3.73-3.73-0.24--3.71-
Other Unusual Items
9.139.131.646.966.6125.84
Pretax Income
145.88135158.81114.27145.4966.3
Income Tax Expense
22.6321.565.3315.2428.3915.78
Earnings From Continuing Operations
123.26113.45153.4899.03117.150.53
Minority Interest in Earnings
-28.49-29.87-21.03-6.47-12.24-24.11
Net Income
94.7683.58132.4592.56104.8626.42
Net Income to Common
94.7683.58132.4592.56104.8626.42
Net Income Growth
8.56%-36.90%43.09%-11.73%296.93%-73.72%
Shares Outstanding (Basic)
569566562566583528
Shares Outstanding (Diluted)
569579573566583528
Shares Change (YoY)
-4.51%1.03%1.19%-2.82%10.26%-10.64%
EPS (Basic)
0.170.150.240.160.180.05
EPS (Diluted)
0.170.140.230.160.180.05
EPS Growth
13.68%-37.54%41.41%-9.17%260.00%-70.59%
Free Cash Flow
130.49189.98294.5960.85115.4897.29
Free Cash Flow Per Share
0.230.330.510.110.200.18
Dividend Per Share
0.1700.1600.1000.1000.1000.050
Dividend Growth
-22.73%60.00%--100.00%-50.00%
Gross Margin
38.29%38.34%36.84%33.04%33.21%42.70%
Operating Margin
10.96%9.52%9.50%7.77%9.29%12.79%
Profit Margin
5.29%4.95%7.92%5.57%6.94%2.24%
Free Cash Flow Margin
7.29%11.25%17.62%3.66%7.64%8.24%
EBITDA
241.45208.02208.85181.79183.42188.41
EBITDA Margin
13.49%12.32%12.49%10.95%12.13%15.95%
D&A For EBITDA
45.3547.3550.0352.7643.0237.31
EBIT
196.11160.67158.82129.04140.39151.09
EBIT Margin
10.96%9.52%9.50%7.77%9.29%12.79%
Effective Tax Rate
15.51%15.97%3.36%13.34%19.51%23.79%
Revenue as Reported
1,7901,6891,6721,6611,5111,181
Advertising Expenses
-14.3510.590.131.4-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.